Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.PanGenex has announced that on April 8, 2008, the company completed the acquisition of Calgenex, a developer and marketer of proprietary formulations to address specific health conditions.
Subscribe to our email newsletter
Calgenex was acquired for 22 million shares of restricted common stock.
Jeff Roman, CEO and president of PanGenex, said: “Completing the acquisition of Calgenex allows us to aggressively begin marketing our proprietary nutraceutical product line through the internet, physician referrals and other retail platforms.”